Cargando…
Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNS
Systemic administration of Nogo-A-neutralizing antibody ameliorates experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. However, the blood-brain barrier (BBB) is a major obstacle limiting the passage of systemically applied antibody to the CNS. To bypass the BBB,...
Autores principales: | Pernet, Vincent, Joly, Sandrine, Spiegel, Sebastian, Meli, Ivo, Idriss, Sherif, Maigler, Frank, Mdzomba, Julius Baya, Roenneke, Anna K., Franceschini, Alessandra, Silvestri, Ludovico, Pavone, Francesco S., Calamai, Martino, Schindowski, Katharina, Chan, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412545/ https://www.ncbi.nlm.nih.gov/pubmed/37558696 http://dx.doi.org/10.1038/s41420-023-01588-7 |
Ejemplares similares
-
Nogo-A inactivation improves visual plasticity and recovery after retinal injury
por: Mdzomba, Julius Baya, et al.
Publicado: (2018) -
Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury
por: Baya Mdzomba, Julius, et al.
Publicado: (2020) -
Selective CNS Targeting and Distribution with a Refined Region-Specific Intranasal Delivery Technique via the Olfactory Mucosa
por: Maigler, Frank, et al.
Publicado: (2021) -
Tau Gene Deletion Does Not Influence Axonal Regeneration and Retinal Neuron Survival in the Injured Mouse Visual System
por: Rodriguez, Léa, et al.
Publicado: (2020) -
B cell-dependent EAE induces visual deficits in the mouse with similarities to human autoimmune demyelinating diseases
por: Joly, Sandrine, et al.
Publicado: (2022)